pillbase.ru

ONAPGO

Active substance: apomorphine

INJECTION, SOLUTION · APOMORPHINE HYDROCHLORIDE 4.9 mg/mL

United StatesActive

Marketing holder: MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 4
  • Апокинон
    раствор для подкожного введения, 5 мг/мл, 10 мл (original in Russian, GRLS)
    ЛП-№(011214)-(РГ-RU)
    Лаборатория Агетан
  • Апокинон
    раствор для подкожного введения, 5 мг/мл, 10 мл (original in Russian, GRLS)
    ЛП-008259
    Лаборатория Агетан
  • Апоморфин
    раствор для подкожного введения, 10 мг/мл, 3 мл (original in Russian, GRLS)
    ЛП-№(015105)-(РГ-RU)
    ООО "Мир-Фарм"
  • ДАЦЕПТОН
    раствор для подкожного введения, 10 мг/мл, 3 мл (original in Russian, GRLS)
    ЛП-№(002136)-(РГ-RU)
    ЭВЕР Нейро Фарма ГмбХ
EU 3
  • Ixense
    apomorphine hydrochloride
    EMEA/H/C/000328
    Takeda Europe R Centre Ltd.
  • Taluvian
    apomorphine hydrochloride
    EMEA/H/C/000386
    Abbott S.r.l.
  • Uprima
    apomorphine hydrochloride
    EMEA/H/C/000327
    Abbott Laboratories Ltd.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-461c-74a6-849c-5b7560c4c602,01a120c3-bfa3-7179-a52e-efd635449a9b,01a120c3-e9e9-73dd-8be9-1b9e99468624,01a120c6-1028-701c-94c0-c94c0580e0c5;count=4 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4f29-7366-b8f8-45a4c6609f26,01a12093-ade0-7220-bd03-54da9fde3810,01a12098-11c6-7625-b1fa-2a9691527444;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
27505-006
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 27505-006 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 27505-006 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 27505-006 · Verified 2026-10-09 · open in source